Intensity Therapeutics, Inc.

NasdaqCM: INTS · Healthcare

Positivity Index

#2,531 / 6,774

Global

#832 / 4,000

United States

Positivity Score

21,414

Rank→

PosiRed: 1 active red flag (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 05 Dec 2025 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

Intensity Therapeutics, Inc. — Overview & Financial Snapshot

Intensity Therapeutics, Inc. (NasdaqCM: INTS) is a Healthcare company, ranked #2,531 of 6,774 companies globally and #832 of 4,000 in United States on PositoAI, with a Positivity Score of 21,414. Its market capitalisation is ₹98.31 Cr ($10.41M), P/E ratio is -0.8 and P/B ratio is 1.13. It currently has 1 active red flag (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

What does Intensity Therapeutics, Inc. do?

Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer relapse and metastasis in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft…

What is Intensity Therapeutics, Inc.'s P/E and P/B ratio?

Intensity Therapeutics, Inc. has a P/E ratio of -0.8 and a P/B ratio of 1.13.

What is Intensity Therapeutics, Inc.'s debt-to-equity ratio?

Intensity Therapeutics, Inc. has a debt-to-equity ratio of 0.01.

How much does Intensity Therapeutics, Inc. owe compared with what it owns?

Intensity Therapeutics, Inc. owes $0.20 for every $1 it owns (balance sheet Jun 2026), which is low.

What is Intensity Therapeutics, Inc.'s Positivity rank?

Intensity Therapeutics, Inc. is ranked #2,531 of 6,774 companies globally and #832 of 4,000 in United States on PositoAI, with a Positivity Score of 21,414.

Does Intensity Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. Intensity Therapeutics, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 05 Dec 2025). It has no yellow flags.

Where can I read the latest news about Intensity Therapeutics, Inc.?

Recent headlines about Intensity Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Intensity Therapeutics, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Intensity Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.